The US National Institue of Health has admitted that participants in the GSK Ebola vaccine trials in Liberia could be infected with Ebola.
In a document called “QUESTIONS AND ANSWERS PREVAIL Phase 2/3 Clinical Trial of Investigational Ebola Vaccine”, the possibility of people being infected with Ebola is clearly stated
“If a study participant becomes infected with Ebola during the course of the clinical trial, he or she will be directed to medical care for treatment.”
As this blog has pointed out, the GSK vaccine is a combination of a cold virus and an Ebola virus. A Merck vaccine with a combination of a similar cold virus and an AIDS virus was found to give people AIDS.
At the very least, NIH is admitting that the experimental vaccine will not protect people against Ebola.
Also, the trial is classified as a phase 2 and 3 trial, suggesting that no…